Aberrant Expression of EZH2 in Pediatric Patients with Myelodysplastic Syndrome: A Potential Biomarker of Leukemic Evolution

Pediatric myelodysplastic syndrome (MDS) is an uncommon disease and little is known about the molecular alterations of its development and evolution to acute myeloid leukemia (AML). The Enhancer of Zeste Homolog 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2 (PCR2). It is a histo...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza Fernandez, Teresa, Fonseca Alvarenga, Tatiana, Almeida Antônio de Kós, Elaiza, Lamim Lovatel, Viviane, Tavares, Rita de Cássia, da Costa, Elaine Sobral, de Souza Fernandez, Cecília, Abdelhay, Eliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925750/
https://www.ncbi.nlm.nih.gov/pubmed/31886200
http://dx.doi.org/10.1155/2019/3176565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925750/
https://www.ncbi.nlm.nih.gov/pubmed/31886200
http://dx.doi.org/10.1155/2019/3176565

Ejemplares similares